Google embraces health care’s AI agentic era

Google embraces health care’s AI agentic era

  • 19.03.2025 02:00
  • politico.com
  • Keywords: AI, Market Growth

Google is developing AI tools using large language models to assist doctors, researchers, and drug developers. These include TxGemma for drug discovery and AMIE for patient data collection before visits. The tools aim to improve efficiency in diagnosing diseases, suggesting treatments, and reviewing scientific literature.

Alphabet News

Estimated market influence

Google

Positivesentiment_satisfied
Analyst rating: N/A

Google is developing AI tools for healthcare professionals and researchers, including TxGemma for drug discovery and AMIE for patient data collection. Their use of Gemini in these applications shows a strong commitment to advancing AI in healthcare.

Beth Israel Deaconess Medical Center

Positivesentiment_satisfied
Analyst rating: N/A

The medical center is collaborating with Google to test the effectiveness of AMIE in gathering patient information pre-visit and enhancing patient care.

Google DeepMind

Positivesentiment_satisfied
Analyst rating: N/A

As part of Google, they are developing advanced AI tools like TxGemma and Gemini-based chatbots for healthcare applications.

Princess Maxima Center

Positivesentiment_satisfied
Analyst rating: N/A

The center is utilizing Google's Gemini to create a bot that aids in selecting personalized cancer treatments for children, significantly reducing the time required for this process.

American Cancer Society

Positivesentiment_satisfied
Analyst rating: N/A

They are using Google's Ana bot to assist patients with cancer-related inquiries and provide support resources.

Vivalink

Negativesentiment_dissatisfied
Analyst rating: N/A

The company is expressing concerns about the lack of permanent telehealth policies, which could hinder their ability to invest in new remote care methods.

Context

Analysis: Google's Embrace of AI in Healthcare and Market Implications

Key Facts and Data Points

  • TxGemma (Drug Discovery):

    • Based on Google’s Gemini AI.
    • Assists pharmaceutical companies with drug discovery by analyzing gene-disease relationships, drug toxicity, and clinical trial potential.
  • AMIE (Patient Care):

    • Deployed at Beth Israel Deaconess Medical Center.
    • Collects patient data pre-visit to enhance care efficiency.
  • "Co-scientist" Bot:

    • Gemini-based tool aiding researchers in literature reviews, hypothesis generation, and proposal composition.
  • Capricorn (Cancer Treatment):

    • Developed at Princess Maxima Center using Gemini.
    • Reduces treatment plan time from 2-3 days to 40 seconds.
  • Ana (Patient Support):

    • American Cancer Society's Gemini-based bot providing cancer diagnosis and treatment information.

Market Trends

  • AI Adoption in Healthcare:
    • AI tools like TxGemma, AMIE, and Capricorn are transforming healthcare efficiency.
    • Potential for significant cost reduction and faster drug development.

Competitive Dynamics

  • Google's Leadership:
    • Leading in AI-driven healthcare solutions with Gemini-based applications.
    • Competitors may need to accelerate their AI initiatives to stay competitive.

Strategic Considerations

  • Regulatory Environment:
    • Uncertainty around telehealth policies could impact investment and innovation.
    • Congress's short-term extensions of pandemic-era rules may hinder long-term planning.

Long-Term Effects

  • Transformative Potential:
    • AI tools like TxGemma, AMIE, and Capricorn could revolutionize healthcare access and cost over the next decade.
    • The rise of telehealth and hospital-at-home programs indicates a significant shift in care delivery.

Conclusion

Google's strategic focus on agentic AI in healthcare positions it as a key player in transforming the industry. While challenges like regulatory uncertainty exist, the potential for efficiency gains and innovation is substantial. Market players must adapt to these trends to remain competitive.